0001209191-23-016046.txt : 20230303 0001209191-23-016046.hdr.sgml : 20230303 20230303195733 ACCESSION NUMBER: 0001209191-23-016046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kassberg Thomas Richard CENTRAL INDEX KEY: 0001303811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 23707064 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-01 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001303811 Kassberg Thomas Richard C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 0 1 0 0 CBO & EVP Common Stock 2023-03-01 4 A 0 2663 0.00 A 230222 D Common Stock 2023-03-01 4 A 0 22000 0.00 A 252222 D Common Stock 2023-03-01 4 S 0 1968 45.27 D 250254 D Common Stock 2023-03-01 4 D 0 3394 45.65 D 246860 D Stock Option (Right to Buy) 45.65 2023-03-01 4 A 0 39400 0.00 A 2033-03-01 Common Stock 39400 39400 D Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric. Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. Represents shares sold to pay required tax withholdings due to the vesting of RSUs. Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. /s/ Karah Parschauer, attorney-in-fact 2023-03-03